AVALON: Another large real-world study comparing ambulatory cardiac monitoring services

Click here to see the study
Support
Support
Search

Transforming healthcare economics through better cardiac diagnosis

Missed or undiagnosed arrhythmias often lead to avoidable hospitalizations, higher costs, and compromised quality measures.1 iRhythm’s evidence-based solutions empower organizations to detect earlier, intervene sooner, and deliver better outcomes at scale.2-4

An image showing a person interacting with another.

Whether you’re advancing value-based care initiatives or managing plan-level quality and cost goals, iRhythm delivers clarity by design

Health plan solutions
See how iRhythm can support lower utilization, improved quality performance, and measurable value across member populations.2-4
Explore health plan solutions
Value-based care programs
See how iRhythm partners with innovative care providers and management companies to lower utilization and improve quality performance.2-4
Explore value-based care programs
  1. Benjamin EJ, Muntner P, Alonso A, et al. Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association. Circulation. 2019;139(10):e56–e528.
  2. Reynolds et al. Comparative effectiveness and healthcare utilization for ambulatory cardiac monitoring strategies in Medicare beneficiaries. Am Heart J. 2024;269:2534. https://doi.org/10.1016/j.ahj.2023.12.002
  3. Russo et al. Assessment of variation in ambulatory cardiac monitoring among commercially insured patients. Am J Manag Care. Published online August 13, 2025. doi:10.37765/ajmc.2026.89782
  4. Zio LTCM service refers to Zio XT and Zio monitor service.

WEB0259.01